SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Strategies & Market TrendsSpeculating in Takeover Targets


Previous 10 Next 10 
From: E_K_S10/10/2019 9:16:29 AM
1 Recommendation   of 6103
 
UCB agrees to buy Ra Pharma for $2.5B
Oct. 10, 2019 6:51 AM ET|About: UCB SA (UCBJF)|By: Douglas W. House, SA News Editor

UCB SA ( OTCPK:UCBJF) has agreed to acquire Ra Pharmaceuticals (NASDAQ: RARX) for $48 per share in cash or $2.5B (€2.2B)($2.1B net of RARX cash).

UCB says the deal is consistent with its "Accelerate and Expand" strategy. In this case, it gains access to RA's zilucoplan, in Phase 3 development for myasthenia gravis (MG), complementing its own rozanolixizumab, also in late-stage development for MG.

Zilucoplan is also being evaluated in other complement-mediated disorders like ALS and immune-mediated necrotizing myopathy.

The transaction will not affect UCB's 2019 financial guidance. It will be dilutive to its mid-term earnings and will extend its mid-term goal of EBITDA/revenue of 31% out one year to 2022.

The deal should close by the end of Q1 2020.

RARX is up 106% premarket on light volume.

Share RecommendKeepReplyMark as Last Read


To: richardred who wrote (5470)10/10/2019 11:22:40 AM
From: richardred
   of 6103
 
ENZ-Speculation

IMO Harbert is seeing what I'm seeing in ENZ IP. Reminds me so much of my successful LPDX pick. RE-
Enzo Biochem Unit Secures New York State Approval for Hepatitis B Virus Clinical Test
BY MT Newswires
— 12:20 PM ET 09/24/2019

Enzo Biochem Wins US Patent for Advanced Nucleic Acid Hybridization Probe Technology
BY MT Newswires
— 2:15 PM ET 08/05/2019


To: richardred who wrote (3456)9/25/2014 11:53:11 PM
From: richardred2 Recommendations Respond to of 5585
Nice surprise to come home tonight to- Bulls Eye # 3 this year LPDX-LipoScience :+ )

LabCorp Acquiring Cholesterol Tester LipoScience By AMY REEVES, INVESTOR'S BUSINESS DAILY

Posted 11:49 AM ET

Medical-testing giant Laboratory Corp. of America (NYSE: LH) agreed to buy startup LipoScience (NASDAQ: LPDX) for $85.3 million in cash Thursday, sending the latter's shares up more than 62% in the stock market today.

LipoScience makes a lipid profile test using nuclear magnetic resonance technology to measure a patient's cholesterol levels and help manage heart disease. The stock went public at 9 in January 2013, but was hammered for over a year, bottoming out below 3 earlier this month. In an email to clients Thursday, ISI Group analyst Michael Cherny wrote that the company's problems are probably behind it.

"We believe that LPDX's test is superior when used for managing patients, and the issues that the company has faced in the past have largely been due to market access (and) negotiating reimbursement rates with third-party vendors," he wrote. "Given our positive view on the test, we believe that LH's commercial infrastructure should drive broader test adoption by removing some of the barriers to market access. Additionally, some payers have been pushing back against tests offered by out-of-network labs, which had impacted LPDX. Given that LH is an in-network provider for most large plans, we expect the above-mentioned payer-related pressures to abate."


View Enlarged Image

By midmorning Thursday, LipoScience's stock was trading a bit below LabCorp's offer price of $5.25 a share. LabCorp's stock was down about 1%, near 103.

Follow Amy Reeves on Twitter: @IBD_AReeves.

Read More At Investor's Business Daily: news.investors.com
Follow us: @IBDinvestors on Twitter | InvestorsBusinessDaily on Facebook

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (3610)10/10/2019 12:07:23 PM
From: richardred
   of 6103
 
KRA-KRATON CORPORATION getting destroyed today. Keeping a close eye on it for a possible entry down the road.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (5550)10/12/2019 12:07:33 PM
From: richardred
   of 6103
 
RE-CTG Speculation recent 13d- Some adds by AGS, but IMO nothing to suggest they have swaying power. I just think they know they have an undervalued stock given forward prospects. I've been watching block trades of late(mostly small trades) and I'm sure AGS is being careful as not to move the needle much.


Share RecommendKeepReplyMark as Last Read


From: richardred10/12/2019 4:19:28 PM
   of 6103
 
The Big Five: Largest Acquisitions by Tech Company



Share RecommendKeepReplyMark as Last Read


From: E_K_S10/14/2019 8:47:16 AM
   of 6103
 
Wonder if we see more of these mergers?

Utilities PPL, Avangrid in merger talks - FT
Oct. 14, 2019 8:15 AM ET|About: PPL Corporation (PPL)|By: Carl Surran, SA News Editor

PPL Corp. (NYSE: PPL) and Avangrid (NYSE: AGR) are in talks to combine their businesses, in a deal that would create one of the largest publicly traded utilities in the U.S. if it completes, Financial Times reports.

AGR, the third biggest U.S. wind power provider, serves 3.1M customers in upstate New York and New England, while PPL covers 1.4M customers in 29 counties.

It is unclear whether a deal would include an investment from Spanish utility Iberdrola ( OTCPK:IBDRY), which owns more than 80% of AGR.

Share RecommendKeepReplyMark as Last Read


From: E_K_S10/14/2019 10:03:28 AM
   of 6103
 
FreshDirect on the sales block
Oct. 14, 2019 8:29 AM ET|About: Amazon.com, Inc. (AMZN)|By: Clark Schultz, SA News Editor

FreshDirect is looking for a buyer, according to New York Post.

Amazon (NASDAQ: AMZN) and Walmart (NYSE: WMT) have both been kicking FreshDirect's tires with looks at the financials and performance data.

FreshDirect's "bungled" move to The Bronx is believed to be a catalyst for the sale exploration.

Share RecommendKeepReplyMark as Last Read


From: richardred10/14/2019 11:43:40 AM
1 Recommendation   of 6103
 
Sold out of KEM & HZO positions today. Locking up nice profits in both. I still like both companies and the ones I sold earlier.I may re-enter some at a later opportune time. Sold out of MOD -TDC & WCC about a month ago, all profitable trades.

Share RecommendKeepReplyMark as Last ReadRead Replies (4)


To: richardred who wrote (5161)10/14/2019 2:09:26 PM
From: richardred
   of 6103
 
Good thing I was out of JAG - It would have been another take-under for myself, like Wildhorse. However Parsley could look interesting in due time.

Parsley Energy to buy Jagged Peak in $1.62 billion shale expansion.

(Reuters) - U.S. shale producer Parsley Energy Inc ( PE.N) on Monday agreed to buy smaller peer Jagged Peak Energy Inc ( JAG.N) in an all-stock deal valued at $1.62 billion, adding acreage in an oil-rich part of the top U.S. shale basin.

reuters.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (5592)10/14/2019 8:22:01 PM
From: robert b furman
   of 6103
 
Excellent trading Rick!

Kudos.

Bob

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10